NAGE
Niagen Bioscience, Inc.
NASDAQ: NAGE · HEALTHCARE · BIOTECHNOLOGY
$4.76
-1.65% today
Updated 2026-04-29
Market cap
$381.18M
P/E ratio
23.80
P/S ratio
2.95x
EPS (TTM)
$0.20
Dividend yield
—
52W range
$4 – $15
Volume
1.2M
Niagen Bioscience, Inc. (NAGE) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.76
12-Month target
$3.62
2030 Target
—
Intrinsic (DCF)
$6.93
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 23.80x (capped 25x) · Margin: 13.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.